Abstract
Viral heart disease (VHD) is an important clinical disease entity both in pediatric as well as adult cardiology. Coxsackieviruses (CVBs) are considered an important cause for VHD in both populations. VHD may lead to dilated cardiomyopathy and heart failure which can ultimately require heart transplantation. However, no specific treatment modality is so far available. We and others have shown that coxsackieviral replication and cytotoxicity can be successfully targeted by RNA interference, thus leading to increased cell viability and even prolongation of survival in vivo. However, considerable limitations have to be solved before this novel therapeutic approach may enter the clinical trials arena.
Keywords
- Human Immunodeficiency Virus Type
- Respiratory Syncytial Virus
- Respiratory Syncytial Virus Infection
- Lock Nucleic Acid
- siRNA Molecule
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Download to read the full chapter text
Chapter PDF
References
Abrahante J, Daul A, Li M et al (2003) The Caenorhabditis elegans hunchback-like gene lin-57/hbl-1 controls developmental time and is regulated by microRNAs. Dev Cell 4:625–637
Ahn J, Jun E, Lee H et al (2005) A small Interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge. J Virol 79:8620–8624
Alisky J, Davidson B (2004) Towards therapy using RNA interference. Am J Pharmacogenomics 4:45–51
Allerson C, Sioufi N, Jarres R et al (2005) Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J Med Chem 48:901–904
Arts G, Langemeijer E, Tissingh R et al (2003) Adenoviral vectors expressing siRNAs for discovery and validation of gene function. Genom Res 13:2325–2332
Badorff C, Lee G, Lamphear B et al (1999) Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an aquired cardiomyopathy. Nat Med 5:320–326
Barik S (2005) Silence of the transcripts: RNA interference in medicine. J Mol Med 83:764–773
Bauer S, Gottesman G, Sirota L et al (2002) Severe coxsackie virus B infection in preterm newborns treated with pleconaril. Eur J Pediatr 161:491–493
Bergelson J, Cunningham J, Droguett G et al (1997) Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320–1323
Bernstein E, Caudy A, Hammond S et al (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363–366
Bhuyan P, Kariko K, Capodici J et al (2004) Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes. J Virol 78:10276–10281
Billy E, Brondani V, Zhang H et al (2001) Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc Natl Acad Sci USA 98:14428–14433
Bitko V, Barik S (2001) Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol 1:34
Bitko V, Musiyenko A, Shulyayeva O et al. (2005) Inhibition of repiratory viruses by nasally administered siRNA. Nat Med 11:50–55
Boden D, Pusch O, Lee F et al (2003) Human immunodeficiency virus type 1 escape from RNA interference. J Virol 77:11531–11535
Bohula E, Salisbury A, Sohail M et al (2003) The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript. J Biol Chem 278:15991–15997
Braasch D, Jensen S, Liu Y et al (2003) RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 42:7967–7975
Brennecke J, Hipfner D, Stark A et al (2003) Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113:25–36
Brown K, Chu C, Rana T (2005) Target accessibility dictates the potency of human RISC. Nat Struct Mol Biol 12:469–470
Brummelkamp T, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553
Chen Z, Indjeian V, McManus M et al (2002) CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. Dev Cell 3:339–350
Chi J, Chang H, Wang N et al (2003) Genomewide view of gene silencing by small interfering RNAs. Proc Natl Acad Sci USA 100:6343–6346
Coburn G, Cullen B (2002) Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 76:9225–9231
Das AT, Brummelkamp T, Westerhout E et al (2004) Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 78:2601–2605
deFougerolles A, Manoharan M, Meyers R et al (2005) RNA interference in vivo: towards synthetic small inhibitory RNA-based therapeutics. Methods Enzymol 392:278–296
Ding Y, Chan C, Lawrence C (2004) Sfold web server for statistical folding and rational design of nucleic acids. Nucleic Acids Res 32:135–141
Dorsett Y, Tuschl T (2004) siRNAs: application in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3:318–329
Downward J (2004) RNA interference. BMJ 328:1245–1248
Dykxhoorn D, Novina C, Sharp P (2003) Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4:457–467
Elbashir S, Harborth J, Lendeckel W et al (2001a) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498
Elbashir S, Lendeckel W, Tuschl T (2001b) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15:188–200
Elmen J, Thonberg H, Ljungberg K et al (2005) Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res 33:439–447
Fechner H, Pinkert S, Wang X et al (2007) Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor. Gene Ther 14:960–971
Feldman A, McNamara D (2000) Myocarditis. N Engl J Med 343:1388–1398
Feuer R, Mena I, Pagarigan R et al (2003) Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol 163:1379–1393
Fire A, Xu S, Montgomery M et al (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806–811
Friedrich I, Shir A, Klein S et al (2004) RNA molecules as anti-cancer agents. Semin Cancer Biol 14(4):223–230
Gartel A, Kandel E (2006) RNA interference in cancer. Biomol Eng 23(1):17–34
Ge Q, McManus M, Nguyen T et al (2003) RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci USA 100:2718–2723
Ge Q, Filip L, Bai A et al (2004) Inhibition of influenza virus production in virus infected mice by RNA interference. Proc Natl Acad Sci USA 101:8676–8681
Giladi H, Ketzinel-Gilad M, Rivkin L et al (2003) Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 8:769–776
Gitlin L, Karelsky S, Andino R (2002) Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418:430–434
Gitlin L, Stone J, Andino R (2005) Poliovirus Escape from RNA Interference: short interfering RNA-target recognition and implications for therapeutic approaches. J Virol 79:1027–1035
Grishok A, Mello C (2002) RNAi (Nematodes: Caenorhabditis elegans). Adv Genet 46:339–360
Hamasaki K, Nakao K, Matsumoto K et al (2003) Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett 543:51–54
Hammond S, Bernstein E, Beach D et al (2000) An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404:293–296
Hammond S, Caudy A, Hannon G (2001) Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet 2:110–119
Harborth J, Elbashir S, Vandenburgh K et al (2003) Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev 13:83–105
Heale B, Soifer H, Bowers C et al (2005) siRNA target site secondary structure predictions using local stable substructures. Nucleic Acids Res 33:e30
Holen T, Amarzguioui M, Wiiger M et al (2002) Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res 30(8):1757–1766
Hu W, Myers C, Kilzer J et al (2002) Inhibition of retroviral pathogenesis by RNA interference. Curr Biol 12:1301–1311
Jacque J, Triques K, Stevenson M (2002) Modulation of HIV-1 replication by RNA interference. Nature 418:435–438
Ji J, Wernli M, Klimkait T et al (2003) Enhanced gene silencing by the application of multiple specific small interfering RNAs. FEBS Lett 552:247–252
Kanda T, Steele R, Ray R et al (2007) Small interfering RNA targeted to hepatitis C virus 5′ nontranslated region exerts potent antiviral effect. J Virol 81:669–676
Kandolf R, Klingel K, Zell R et al (1993) Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology 35:140–151
Kapadia S, Brideau-Andersen A, Chisari F (2003) Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci USA 100:2014–2018
Kartasheva N, Contente A, Lenz-Stoppler C et al (2002) P53 induces the expression of its antagonist p73 delta N, establishing an autoregulatory feedback loop. Oncogene 21:4715–4727
Kennerdell J, Carthew R (1998) Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell 95:1017–1026
Khvorova A, Reynolds A, Jayasena S (2003) Functional siRNAs and miRNAs exhibit strand bias. Cell 115:209–216
Kim J, Chung S, Hwang H et al (2007) Expression of short hairpin RNAs against the coxsackievirus B3 exerts potential antiviral effects in COS-7 cells and in mice. Virus Res 125:9–13
Knowlton K, Badorff C (1999) The immune system in viral myocarditis: maintaining the balance. Circ Res 85:559–561
Krönke J, Kittler R, Buchholz F et al (2004) Alternative approaches for efficient inhibition of hepatitis C virus replication by small interfering RNAs. J Virol 78:3436–3446
Lassus P, Opitz-Araya X, Lazebnik Y (2002) Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297:1352–1354
Layzer J, McCaffrey A, Tanner A et al (2004) In vivo activity of nuclease-resistant siRNAs. RNA 10:766–771
Lee NS, Dohjima T, Bauer G et al (2002) Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 20:500–505
Lee MT, Coburn G, McClure M et al (2003) Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus virus. J Virol 77:11964–11972
Li M, Kim J, Li S et al (2005) Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. Mol Ther 12:900–909
Luo K, Chang D (2004) The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted region. Biochem Biophys Res Commun 318:303–310
McCaffrey A, Meuse L, Pham T et al (2002) RNA interference in adult mice. Nature 418:38–39
McCaffrey A, Nakai H, Pandey K et al (2003) Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 21:639–644
McCown M, Diamond M, Pekosz A (2003) The utility of siRNA transcripts produced by RNA polymerase I in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses. Virology 313:514–524
Merl S, Wessely R (2007) Anti-coxsackieviral efficacy of RNA interference is highly dependent on genomic target selection and emergence of escape mutants. Oligonucleotides 17:44–53
Merl S, Michaelis C, Jaschke B et al (2005) Targeting 2A protease by RNA interference attenuates coxsackievirale cytopathogenicity and promotes survival in highly susceptible mice. Circulation 111:1583–1592
Miyagishi M, Taira K (2002) U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 20:497–500
Morrissey D, Blanchard K, Shaw L et al (2005a) Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 41:1349–1356
Morrissey D, Lockridge J, Shaw L et al (2005b) Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 23:1002–1007
Muller U, Steinhoff U, Reis L et al (1994) Functional role of type I and type II interferons in antiviral defense. Science 264:1918–1921
Novina C, Murray M, Dykxhoorn D et al (2002) siRNA-directed inhibition of HIV-1 infection. Nat Med 8:681–686
Omi K, Tokunaga K, Hohjoh H (2004) Long-lasting RNAi activity in mammalian neurons. FEBS Lett 558:89–95
Palauqui J, Vaucheret H (1998) Transgenes are dispensable for the RNA degradation step of cosuppression. Proc Natl Acad Sci USA 95:9675–9680
Palliser D, Chowdhury D, Wang Q et al (2006) An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439:89–94
Park W, Hayafune M, Miyano-Kurosaki N et al (2003) Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells. Gene Ther 10:2046–2050
Paul C, Good P, Winer I et al (2002) Effective expression of small interfering RNA in human cells. Nat Biotechnol 20:505–508
Prabhu R, Garry R, Dash S (2006) Small interfering RNA targeted to stem–loop II of the 5′ untranslated region effectively inhibits expression of six HCV genotypes. Virol J 3:100
Qin X, An D, Chen I et al (2003) Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 100:183–188
Randall G, Rice C (2004) Interfering with hepatitis C virus RNA replication. Virus Res 102:19–25
Reynolds A, Leake D, Boese Q et al (2004) Rational siRNA design for RNA interference. Nat Biotechnol 22:326–330
Rodriguez-Lebron E, Gonzalez-Alegre P (2006) Silencing neurodegenerative disease: bringing RNA interference to the clinic. Expert Rev Neurother 6:223–233
Rossi J (2006) RNAi as a treatment for HIV-1 infection. Biotechniques 40(Suppl):25–29
Rubinson D, Dillon C, Kwiatkowski A et al (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33:401–406
Schubert S, Grunert H, Zeichhardt H et al (2005) Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAs. J Mol Biol 346:457–465
Schwarz D, Hutvanger G, Du T et al (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell 115:199–208
Shankar P, Manjunath N, Lieberman J (2005) The prospect of silencing disease using RNA interference. JAMA 293:1367–1373
Shlomai A, Shaul Y (2003) Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37:764–770
Stark G, Kerr I, Williams B, Silvermann R et al (1998) How cells respond to interferons. Annu Rev Biochem 67:227–264
Stein P, Svoboda P, Anger M et al (2003) RNAi: mammalian oocytes do it without RNA-dependent RNA polymerase. RNA 9:187–192
Thomas C, Ehrhardt A, Kay M (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4:346–358
Tompkins S, Lo C, Tumpey T et al (2004) Protection against lethal influenza virus challenge by RNA interference in vivo. Proc Natl Acad Sci USA 101:8682–8686
Tuschl T, Borkhardt A (2002) Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy. Mol Interv 2:158–167
Vickers T, Koo S, Bennett C et al (2003) Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agent. J Biol Chem 278:7108–7118
Voinnet O, Vain P, Angell S et al (1998) Systemic spread of sequence-specific transgene RNA degradation in plants is initiated by localized introduction of ectopic promoterless DNA. Cell 95:177–187
Wang Q, Contag C, Ilves H et al (2005) Small hairpin RNAs efficiently inhibit hepatitis C IRES-mediated gene expression in human tissue culture cells and a mouse model. Mol Ther 12:562–568
Werk D, Schubert S, Lindig V et al (2005) Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor. Biol Chem 386:857–863
Wessely R, Henke A, Zell R et al (1998a) Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 98:450–457
Wessely R, Klingel K, Santana L et al (1998b) Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444–1453
Wessely R, Klingel K, Knowlton K et al (2001) Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 103:756–761
Wilson J, Jayasena S, Khvorova A et al (2003) RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc Natl Acad Sci USA 100:2783–2788
Woodruff J (1980) Viral myocarditis. A review. Am J Pathol 101:425–484
Yang S, Tutton S, Pierce E et al (2001) Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol Cell Biol 21:7807–7816
Ying C, DeClercq E, Neyts J (2003) Selective inhibition of hepatitis B virus replication by RNA interference. Biochem Biophys Res Commun 309:482–484
Yokota T, Sakamoto N, Enomoto N et al (2003) Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep 4:602–608
Yoshinari K, Miyagishi M, Taira K (2004) Effects on RNAi of the tight structure, sequence and position of the targeted region. Nucleic Acids Res 32:691–699
Yu J, DeRuiter S, Turner D (2002) RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 99:6047–6052
Yuan J, Cheung P, Zhang H et al (2005) Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand. J Virol 79:2151–2159
Zaragoza C, Ocampo C, Saura M et al (1999) Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. J Immunol 163:5497–5504
Zhang W, Yang H, Kong X et al (2005) Inhibition of respiratory syncytial virus infection with intranasal nanoparticles targeting the viral NS1 gene. Nat Med 11:56–62
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Merl, S., Wessely, R. (2008). Targeting Viral Heart Disease by RNA Interference. In: Erdmann, V.A., Poller, W., Barciszewski, J. (eds) RNA Technologies in Cardiovascular Medicine and Research. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78709-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-540-78709-9_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78708-2
Online ISBN: 978-3-540-78709-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)